American Vanguard Corp.
- AVD · NYSE
- Agricultural Chemicals
- Newport Beach, CA
- 739 employees
- CIK 0000005981
Updated from SEC filings through
Top things to know
Revenue, FY2025$515M-5.9% vs FY2024Operating margin-5.5%Operating income -$28.3MEmployees739As of December 31, 2025Next earningsNovember 9, 202616:30 ETLatest 8-KDeparture or appointment of directors or officers; compensationFiled October 1, 2026Leadership changeItem 5.02 filedOctober 1, 2026, last 90 days
Executives
- Douglas Kaye CHIEF EXECUTIVE OFFICER 4, 2026-07-14
- David T. Johnson Chief Financial Officer 10-K, 2026-03-16
- Michael Joseph DiPaola Chief Commercial Officer 4, 2026-06-05
- Jared Straley SVP Operations & Supply Chain 4, 2026-06-05
- Nolteanous Gilliam SVP Manufacturing 4, 2026-06-05
- Shirin Khosravi CHRO 4, 2026-06-05
American Vanguard Corp is a U.S. public company in agricultural chemicals (SIC 2870), headquartered in Newport Beach, CA. It trades as AVD on NYSE. Revenue was $515M in the fiscal year ending December 31, 2025, -5.9% from the year before. It reported about 739 employees. Douglas Kaye is CHIEF EXECUTIVE OFFICER.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $515M 10-K/A, 2026-09-30 | $547M 10-K/A, 2026-09-30 | $579M 10-K/A, 2026-09-30 | $610M 10-K, 2025-05-29 | $558M 10-K, 2024-03-28 |
| Operating income | -$28.3M 10-K/A, 2026-09-30 | -$102M 10-K/A, 2026-09-30 | $23.3M 10-K/A, 2026-09-30 | $40.7M 10-K, 2025-05-29 | $30.9M 10-K, 2024-03-28 |
| SG&A | $111M 10-K/A, 2026-09-30 | $120M 10-K/A, 2026-09-30 | $117M 10-K/A, 2026-09-30 | $120M 10-K, 2025-05-29 | $111M 10-K, 2024-03-28 |
| Net income | -$49.9M 10-K/A, 2026-09-30 | -$126M 10-K/A, 2026-09-30 | $7.5M 10-K/A, 2026-09-30 | $27.4M 10-K, 2025-05-29 | $18.6M 10-K, 2024-03-28 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Douglas Kaye | CHIEF EXECUTIVE OFFICER | 4, 2026-07-14 |
| David T. Johnson | Chief Financial Officer | 10-K, 2026-03-16 |
| Michael Joseph DiPaola | Chief Commercial Officer | 4, 2026-06-05 |
| Shayne Wetherall | Named in proxy bio: President of the Company's Specialty businesses | DEF 14A, 2026-04-23 |
| Jared Straley | SVP Operations & Supply Chain | 4, 2026-06-05 |
| Nolteanous Gilliam | SVP Manufacturing | 4, 2026-06-05 |
| Shirin Khosravi | CHRO | 4, 2026-06-05 |
| Rubin McDougal | Board member (per proxy) bio: director | DEF 14A, 2026-04-23 |
| Carmen Tiu De Mino | Director | 10-K, 2026-03-16 |
| Émer Gunter | Director | 10-K, 2026-03-16 |
| Keith M. Rosenbloom | Director | 10-K, 2026-03-16 |
| Marisol Angelini | Director | 10-K, 2026-03-16 |
| Mark R. Bassett | Director | 10-K, 2026-03-16 |
| Patrick E. Gottschalk | Director | 10-K, 2026-03-16 |
| Scott D. Baskin | Director | 10-K, 2026-03-16 |
| Steven D. Macicek | Director | 10-K, 2026-03-16 |
What American Vanguard Corp does
American Vanguard Corporation (“AVD”) was incorporated under the laws of the State of Delaware in January 1969 and operates as a holding company. The Company conducts its business through its principal operating subsidiaries, including AMVAC Chemical Corporation (“AMVAC”) for its domestic business and AMVAC Netherlands BV (“AMVAC BV”) for its international business.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 29.6 million (as of November 4, 2026) | 10-Q, November 9, 2026 |
|---|---|---|
| Public float | $111M (as of June 30, 2025) | 10-K/A, September 30, 2026 |
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 9, 2026 |
| Latest proxy statement | Meeting June 3, 2026 (filed April 23, 2026) | DEF 14A, April 23, 2026 |
| Auditor | Deloitte & Touche LLP (Costa Mesa, California) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| August 18, 2026 | Keith M. Rosenbloom Director | Sale | 556,580 | $1.2M | Form 4, August 20, 2026 |
| August 17, 2026 | Steven D. Macicek Director | Buy | 19,000 | $40K | Form 4, August 18, 2026 |
| June 3, 2026 | Douglas Kaye CHIEF EXECUTIVE OFFICER | Buy | 5,000 | $13K | Form 4, June 8, 2026 |
| May 19, 2026 | Patrick E. Gottschalk Director | Buy | 25,000 | $68K | Form 4, May 19, 2026 |
| May 13, 2026 | Patrick E. Gottschalk Director | Buy | 40,000 | $117K | Form 4, May 19, 2026 |
| September 4, 2025 | Peter Eilers See Remarks | Sale | 6,000 | $32K | Form 4, September 5, 2025 |
Recent 8-K events
- 8-K filed 2026-10-01
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-11
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-08
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- Item 8.01 Other events
- 8-K filed 2026-04-15
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-03-19
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-03-18
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-11-12
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2025-08-19
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2025-08-01
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2025-07-07
- Item 5.07 Submission of matters to a vote of security holders
- Item 8.01 Other events
Frequently asked questions about American Vanguard Corp
- What does American Vanguard Corp do?
- In its own words, from Item 1 of its 10-K: "American Vanguard Corporation (“AVD”) was incorporated under the laws of the State of Delaware in January 1969 and operates as a holding company. The Company conducts its business through its principal operating subsidiaries, including AMVAC Chemical Corporation (“AMVAC”) for its domestic business and AMVAC Netherlands BV (“AMVAC BV”) for its international business."
- What is American Vanguard Corp's revenue?
- $515M for the fiscal year ending December 31, 2025, from its 10-K/A filed September 30, 2026.
- Is American Vanguard Corp profitable?
- American Vanguard Corp reported net income of -$49.9M for the fiscal year ending December 31, 2025.
- How many employees does American Vanguard Corp have?
- About 739 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of American Vanguard Corp?
- Douglas Kaye, CHIEF EXECUTIVE OFFICER, as named in a 4 filed July 14, 2026.
- Who is the CFO of American Vanguard Corp?
- David T. Johnson, Chief Financial Officer, as named in a 10-K filed March 16, 2026.
- Where is American Vanguard Corp headquartered?
- Newport Beach, CA.
- What is American Vanguard Corp's stock ticker?
- AVD on NYSE.
- What industry is American Vanguard Corp in?
- Agricultural Chemicals, SIC code 2870.
- What is American Vanguard Corp's website?
- american-vanguard.com.
- When does American Vanguard Corp report earnings next?
- November 9, 2026 at 16:30. Source: pg_future_events.
- Is American Vanguard Corp a public company?
- Yes. American Vanguard Corp files with the SEC under CIK 0000005981 and trades as AVD.
- Who audits American Vanguard Corp?
- Deloitte & Touche LLP, Costa Mesa, California, as named in its latest annual report (10-K).
- How many shares of American Vanguard Corp are outstanding?
- 29.6 million shares as of November 4, 2026, from its 10-Q filed November 9, 2026.
- What is American Vanguard Corp's public float?
- $111M as of June 30, 2025, as reported on the cover of its 10-K/A filed September 30, 2026.
- How many business segments does American Vanguard Corp report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 9, 2026.
- When is American Vanguard Corp's annual shareholder meeting?
- June 3, 2026, per its proxy statement (DEF 14A) filed April 23, 2026.
- Have American Vanguard Corp insiders traded stock recently?
- Since September 4, 2025, officers and directors reported 2 open-market sales worth about $1.3M and 4 purchases worth about $237K on Forms 4 and 5. The most recent: Keith M. Rosenbloom (Director) sold 556,580 shares on August 18, 2026.